Global Atherectomy Devices Market to Grow at 8% CAGR, Driven by PAD & CAD Prevalence by 2030

The global atherectomy devices market is expected to grow at a CAGR of ~8% during the forecast period. The increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), a surge in the aging population, rising incidence of diabetes and obesity, growing preference for minimally invasive procedures, and the expanding availability of outpatient and ambulatory surgical centers are some of the key factors driving the market growth. However, high costs of advanced atherectomy devices and procedures remain a major constraint for the growth of the atherectomy devices market. 

The atherectomy devices market is focused on designing and developing medical devices used to remove atherosclerotic plaque from blood vessels, particularly in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). These devices support minimally invasive catheter-based, image-guided procedures that restore proper blood flow in narrowed or blocked arteries, offering an alternative to conventional surgical interventions like bypass surgery.

The market includes directional, rotational, orbital, and laser atherectomy systems, along with supporting accessories and disposable products used in vascular intervention treatments. Common diagnostic techniques for detecting arterial blockages include Doppler ultrasound, angiography, magnetic resonance angiography (MRA), and computed tomography angiography (CTA), which aid in evaluating the extent and precise location of plaque accumulation before performing an atherectomy.

Download a free sample report now 👉
https://meditechinsights.com/atherectomy-devices-market/request-sample/

Rising demand for minimally invasive treatments drives atherectomy device utilization

The growing preference for minimally invasive procedures is a key driver fuelling the demand for atherectomy devices, especially in vascular care. These procedures offer multiple benefits compared to traditional methods, such as shorter hospital stays, quicker recovery times, reduced post-operative complications, and better overall patient outcomes. As a result, they are gaining widespread acceptance among both patients and healthcare providers.

Atherectomy is becoming a preferred treatment option for peripheral artery disease (PAD), as it targets the removal of atherosclerotic plaque from blood vessels using specialized catheters, offering high precision with minimal trauma to the arterial walls. Unlike traditional open surgeries, atherectomy preserves the vessel’s natural structure, reduces the likelihood of restenosis, and may eliminate the need for stents or bypass surgeries. These benefits, along with growing regulatory support and approval for innovative atherectomy technologies, are accelerating the integration of such devices into standard vascular care protocols, thereby driving their growing adoption globally.

AI-Driven robotics and combination therapies accelerate growth in the atherectomy devices market

Advancements in AI, robotics, and combination therapies are transforming vascular procedures and accelerating the growth of the atherectomy devices market. AI integration in atherectomy procedures, particularly in image-guided interventions, has introduced real-time analytics, enhanced lesion detection, and intelligent navigation support. These capabilities aid clinicians in making more informed intraoperative decisions, improving procedural efficiency and safety. Robotics further complements this shift by providing precise catheter control, reduced human intervention, and mitigating physician fatigue, especially during complex, lengthy peripheral interventions.

Another transformative trend is the increasing adoption of combination therapies, which is the incorporation of drug-coated balloons (DCBs) after atherectomy. When this sequence is followed, the therapeutic agent penetrates more deeply into the vessel wall, enhancing efficacy and reducing neointimal hyperplasia. Additionally, some clinical studies have shown that the combination therapies can reduce restenosis rates by a significant percentage compared to balloon angioplasty alone.

Competitive Landscape Analysis

The global atherectomy devices market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company; Medtronic plc; Koninklijke Philips N.V.; Boston Scientific Corporation; Abbott Laboratories Inc.; Avinger, Inc.; AngioDynamics, Inc.; BIOTRONIK.; Rex Medical, L.P. and OrbusNeich Medical Group Holdings Limited, among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 Download a sample report for in-depth competitive insights
https://meditechinsights.com/atherectomy-devices-market/request-sample/

Global Atherectomy Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global atherectomy devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

• Directional Atherectomy Devices
• Rotational Atherectomy Devices
• Orbital Atherectomy Devices
• Laser Atherectomy Devices
• Others

Market Size & Forecast (2023-2030), By Application, USD Million

• Peripheral Vascular
• Cardiovascular
• Neurovascular
• Others

Market Size & Forecast (2023-2030), By End-user, USD Million

• Hospitals
• Ambulatory Surgical Centers
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Latin America
• Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com